A program to help lung cancer patients manage their symptoms and improve quality of life
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
NA · The University of Hong Kong · NCT06377124
This study tests a mobile program that helps lung cancer patients manage their symptoms and improve their quality of life, while also looking at how it affects their family caregivers.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 320 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Locations | 3 sites (Hong Kong, Ho ManTin and 2 other locations) |
| Trial ID | NCT06377124 on ClinicalTrials.gov |
What this trial studies
This study evaluates the Smart Self-Management Support Programme (3S), which utilizes mobile devices to assist lung cancer patients in managing their symptoms and improving their quality of life. The program focuses on empowering patients through self-management techniques and aims to enhance their knowledge, skills, and confidence in handling their condition. Participants will be compared to a control group receiving general health information to assess the effectiveness of the 3S intervention. Additionally, the study will examine the impact on family caregivers of the patients involved.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and above with advanced-stage non-small cell lung cancer who are capable of self-care and can communicate in Chinese.
Not a fit: Patients preparing for lung surgery, those with severe respiratory issues, or uncontrolled pain may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life for lung cancer patients by providing them with effective self-management tools.
How similar studies have performed: Other studies have shown promise in using digital self-management programs for cancer patients, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients: Inclusion Criteria: * Aged 18 years or above * Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer * Ambulatory and capable of all self-care activities (ECOG ≤2) * Either undergoing or has finished oncology therapy * Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators * Can speak and read Chinese * Willing to complete the patient-reported outcome questionnaire * Has a smartphone with WhatsApp or WeChat Exclusion Criteria: * Preparing for lung operation * Skeletal fragility * Serious active infection * Inability to walk * Previously untreated symptomatic brain metastases * Severe respiratory insufficiency * Uncontrolled pain * Diagnosed psychiatric illness with or without medication Family Caregivers: Inclusion criteria: * Aged 18 years or above * Family caregivers of recruited patients Exclusion criteria: * Unable to speak and read Chinese * Unwilling to complete the patient-reported outcome questionnaire
Where this trial is running
Hong Kong, Ho ManTin and 2 other locations
- Queen Elizabeth Hospital — Hong Kong, Ho ManTin, Hong Kong (RECRUITING)
- Queen Mary Hospital — Hong Kong, Hong Kong (NOT_YET_RECRUITING)
- United Christian Hospital — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Agnes Yuen Kwan Lai, PhD — School of Nursing and Health Sciences
- Study coordinator: Agnes Yuen Kwan Lai, PhD
- Email: ayklai@hkmu.edu.hk
- Phone: 852 3970 2917
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer